ICS 2022: Compliance With Uresta (Cure) Study; A 12 Month Follow-Up Of 40 Women
Forty-six women were recruited with an average age of 42 yrs, BMI of 24, and parity of 2.3. The most common activities were running (48%) and CrossFit (22%). Compliance was 90% at 12 months (n=40, 6 withdrew after 2 weeks). Uresta insertion was 'okay', 'easy' or 'very easy' for 86% of participants, and removal was 'okay', 'easy' or 'very easy' for 75% of participants, Leakage was improved (n=13), greatly improved (n=12) or stopped (n=5) for 83% of participants, 75% were ‘much better’ or ‘very much better’ on the PGI-I scale, and 94% would recommend Uresta to a friend. There were no adverse events. The authors conclude that the Uresta bladder support is a safe, effective, user-friendly management option for women with SUI during exercise with 90% compliance at 12 months.
Presented by: Patrick Campbell, Kingsbridge Private Hospital, Belfast, United Kingdom
Written by: Diane Newman, DNP, CRNP, FAAN, BCB-PMD, Urologic Nurse Practitioner, Adjunct Professor of Urology in Surgery, Senior Research Investigator, Perelman School of Medicine, University of Pennsylvania during the International Continence Society Annual Meeting, September 7-10, 2022, Vienna, Austria.